175250 — Icure Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Market Cap
KR₩71bn
Enterprise Value
KR₩140bn
Revenue
KR₩57bn

Annual balance sheet for Icure Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	36,175	13,718	24,417	53,786	8,558
Net Total Accounts Receivable
Net Total Receivables	15,075	17,350	17,144	16,221	8,986
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	68,897	43,726	58,796	80,705	31,812
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	97,306	107,813	101,312	96,943	93,526
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	215,798	195,149	215,448	224,121	166,137
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	36,787	34,110	54,818	109,981	95,439
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	118,267	82,995	119,693	134,450	107,900
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	97,531	112,154	95,755	89,671	58,238
Total Liabilities & Shareholders' Equity	215,798	195,149	215,448	224,121	166,137
Total Common Shares Outstanding